Harald Schnidar, CEO and Founder of SCARLETRED, will be present as a panelist at Exporttag 2026 (Export Day 2026) - one of Central Europe’s most significant events for international business and cross-border economic development.

The event will take place on May 28th, 2026, at the Austrian Economic Chamber in Vienna.

This invitation represents a significant recognition of Harald Schnidar’s expertise in navigating complex international markets, and a unique opportunity for SCARLETRED to share its vision for the future of dermatology on a global stage.

Exporttag 2026: Where international business comes to life

Organized by the Austrian Economic Chamber (Wirtschaftskammer Österreich - WKO) and AUSSENWIRTSCHAFT AUSTRIA, Exporttag 2026 unites over 3.000 entrepreneurs, international top speakers and export experts under a roof.  

In a world where geopolitical shifts are continuously reshaping market dynamics, the event serves as a critical compass for Austrian companies seeking to expand and evolve internationally.  

Exporttag is a platform where keynotes, panel discussions, workshops, and deep dives converge with personal advisory sessions and networking.

The US Healthcare Market: Opportunities and Challenges for Austria

Harald Schnidar will take the stage as a panelist in the session “The US Healthcare Market in Focus: Opportunities and Challenges for Austrian Companies”, scheduled for May 28, 2026, 14:40-15:20, Main Stage, Julius Raab Saal.

Harald Schnidar will be joined by Christa Bleyleben (Managing Partner, MassGlobalPartners) and Victoria Liedl (Head of Innovation & Technology, AußenwirtschaftsCenter New York), moderated by Damita Pressl.

Together, the panelists will examine the significant growth potential of the US healthcare ecosystem, regulatory frameworks, and partnership models.

Harald Schnidar: Over 15 years of cross-continental business expertise

With more than 15 years of hands-on experience in cross-continental business development, Harald Schnidar brings a rare combination of clinical depth, entrepreneurial vision, and transatlantic market intelligence to the panel.  

As the founder of both SCARLETRED Holding GmbH in Vienna and SCARLETRED Inc. in Cambridge, Massachusetts, Harald Schnidar has successfully built and scaled a MedTech company across two continents - navigating the distinct regulatory, commercial, and cultural landscapes of both the European and US markets.

The invitation to Exporttag 2026 highlights the standing of SCARLETRED in the market: Not only as a pioneer in clinical skin imaging and agentic AI analysis, but as a role model for Austrian companies with ambition to establish a meaningful presence in the USA.

Advancing smartphone-based skin imaging and AI analysis across continents

The company's certified and clinically validated Software as a Medical Device, Scarletred® Vision, is deployed across clinical trial sites globally - a direct result of the cross-continental infrastructure and partnerships Harald Schnidar has built over the years.

The company's presence in Cambridge, MA - home to one of the world's most dynamic life sciences and MedTech ecosystems - reflects a long-term commitment to strengthening its presence in the United States, enhancing partnerships with leading research institutions, biopharma companies, and clinical networks.

By sharing his vision at Exporttag 2026, Harald Schnidar intends to inspire fellow Austrian entrepreneurs to embrace the opportunities of the US healthcare market.  

SCARLETRED is proud to be represented at this landmark event and looks forward to conversations, connections, and collaborations that will emerge from Austria’s most important international business forum.